References
- Fea AM, Durr GM, Marolo P, Malinverni L, Economou MA, Ahmed I. XEN® gel stent: a comprehensive review on its use as a treatment option for refractory glaucoma. Clin Ophthalmol Auckl NZ. 2020;14:1805–1832. doi:10.2147/OPTH.S178348.
- Napoli L, Riva I, Oddone F, Michelessi M, Quaranta L. A rare case of endophthalmitis after bleb needle revision for glaucoma Xen® gel stent. Eur J Ophthalmol. 2021;31(1): NP9–NP12. doi:10.1177/1120672119878016.
- Lim R, Lim KS. XEN implant-related endophthalmitis. Ophthalmology. 2018;125(2):209. doi:10.1016/j.ophtha.2017.10.019.
- Lapira M, Cronbach N, Shaikh SA. Extrusion and breakage of XEN gel stent resulting in endophthalmitis. J Glaucoma. 2018;27(10):934–935. doi:10.1097/IJG.0000000000001058.
- Heidinger A, Schwab C, Lindner E, Riedl R, Mossböck G. A retrospective study of 199 xen45 stent implantations from 2014 to 2016. J Glaucoma. 2019;28(1):75–79. doi:10.1097/IJG.0000000000001122.
- Olgun A, Imamoğlu S, Karapapak M, Düzgün E, Kaçar H. Endophthalmitis after XEN gel stent implantation: 2 cases. J Glaucoma. 2018;27(12):e191–e194. doi:10.1097/IJG.0000000000001076.
- Wisdorf M, Kowalski R, Kiessling D, Roessler GF, Widder RA. A case of endocarditis following endophthalmitis after XEN45 gel stent implantation. J Glaucoma. 2021;30(8):e357–e359. doi:10.1097/IJG.0000000000001869.
- Buffault J, Baudouin C, Labbé A. Is the Xen® gel stent really minimally invasive? Am J Ophthalmol Case Rep. 2020;19:100850. doi:10.1016/j.ajoc.2020.100850.
- Ibáñez-Muñoz A, Soto-Biforcos VS, Rodríguez-Vicente L, et al. XEN implant in primary and secondary open-angle glaucoma: a 12-month retrospective study. Eur J Ophthalmol. 2020;30(5):1034–1041. doi:10.1177/1120672119845226.
- Starr MR, Huang D, Israilevich RN, et al. Endophthalmitis after minimally invasive glaucoma surgery. Ophthalmology. 2021;128(12):1777–1779. doi:10.1016/j.ophtha.2021.06.004.
- Zheng CX, Moster MR, Khan MA, et al. Infectious endophthalmitis after glaucoma drainage implant surgery: clinical features, microbial spectrum, and outcomes. Retina. 2017;37(6):1160–1167. doi:10.1097/IAE.0000000000001329.
- Al-Ani HH, Lu LM, Meyer JJ, Niederer RL. Cataract surgery in herpes simplex virus ocular disease. J Cataract Refract Surg. Published online July 12, 2021. doi:10.1097/j.jcrs.0000000000000745
- Pohlmann D, Pahlitzsch M, Schlickeiser S, et al. Virus-associated anterior uveitis and secondary glaucoma: diagnostics, clinical characteristics, and surgical options. PloS One. 2020;15(2):e0229260. doi:10.1371/journal.pone.0229260.
- Kwon HJ, Kong YXG, Tao LW, et al. Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity. Clin Exp Ophthalmol. 2017;45(5):472–480. doi:10.1111/ceo.12916.
- Iwao K, Inatani M, Seto T, et al. Long-term outcomes and prognostic factors for trabeculectomy with mitomycin c in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma. 2014;23(2):88–94. doi:10.1097/IJG.0b013e3182685167.
- Gedde SJ, Scott IU, Tabandeh H, et al. Late endophthalmitis associated with glaucoma drainage implants. Ophthalmology. 2001;108(7):1323–1327. doi:10.1016/s0161-6420(01)00598-x.